Multispecifics:
Dual Targeting, Singular Precision
Our minimalist binders seamlessly integrate into multispecific constructs, expanding functional binding footprints and enhancing effective binding affinity through bivalency.
With our rapid optimization processes, we can drive functional affinity into the low picomolar regime within weeks, accelerating the development of high-affinity, precision-targeted therapeutics faster than ever before.
This modular, plug-and-play architecture simplifies the creation of bispecifics, enabling the rapid, combinatorial production of “matchmaker” molecules to facilitate novel biological mechanisms, such as targeted protein degradation. By leveraging our platform to explore novel biology, we are moving past traditional drug development limitations, delivering dual targeting with singular precision.
Functional by Design:
Crafting Binders with Purpose
Our platform enables the direct identification of high-affinity binders with tailored functional effects (whether neutralizing, modulating, or binding without interference), offering a new degree of control in therapeutic design.
This tunable functionality enables the rapid development of bespoke therapeutics, optimized for diverse mechanisms of action, from robust receptor silencing to precision pathway modulation.
This isn’t discovery by chance – it’s function by design.
